loder, who hasn't been involved with any cgrp drug studies, cautions that these medicines don't work for everybody. and they may be risky for some people. .
"we are calling for the immediate implementation of a statutory duty of candour for the health trusts." .
marketwatch: "new migraine drugs have promise -- and a ,500 price tag."
218 Used Today
181 Used Today
200 Used Today